2006
DOI: 10.1016/j.breast.2005.02.010
|View full text |Cite
|
Sign up to set email alerts
|

Breast cancer multi-disciplinary teams in England: much achieved but still more to be done

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
19
0
1

Year Published

2007
2007
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(20 citation statements)
references
References 2 publications
0
19
0
1
Order By: Relevance
“…In addition, changes in breast cancer management, such as the introduction of new referral and practice guidelines with respect to breast symptoms and the implementation of MDTs alongside screening in more recent years may be a contributory factor (12,38).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, changes in breast cancer management, such as the introduction of new referral and practice guidelines with respect to breast symptoms and the implementation of MDTs alongside screening in more recent years may be a contributory factor (12,38).…”
Section: Discussionmentioning
confidence: 99%
“…[15][16][17][18][19][20][21] Additional information on the collaborative initiatives was also identified in fifteen published or unpublished sources. [22][23][24][25][26][27][28][29][30][31][32][33][34][35] From the selected articles, information about the clinical domain, objectives, participants, sponsorship, support, infrastructure, methodology, social context, and sustainability were identified.…”
Section: Literature Search Resultsmentioning
confidence: 99%
“…Most often, the meetings are led by a breast surgeon. Although most respondents (95%) described that follow-up involved the Department of Surgery with or without adjuvant chemotherapy, the high level of attendance for medical oncologists was particularly noteworthy given that international audits of MDT functionality consistently reveal that medical oncologists are least likely to attend the meetings, of all medical specialists [6,7]. This is not surprising, however, given that most oncologists in our sample were based in comprehensive or university cancer centers where oncology services are most commonly available.…”
Section: Discussionmentioning
confidence: 99%
“…All newly diagnosed breast cancer patients were discussed in 45% of MDT meetings, a figure less than 60 to 94% noted in studies from the United Kingdom [6,7]. Discussion of benign cases was infrequent (8% of cases).…”
Section: Discussionmentioning
confidence: 99%